IndiaInfoline » Markets » DIVISLAB

Divis Laboratories Ltd - Share Price

DIVISLAB

Open

3,419.50

Prev. Close

3,440.05

Turnover (lac.)

57,212

Day's High

3,485.90

Day's Low

3,326.40

52 Week's High

3,914.95

52 Week's Low

1,626.00

Book Value

331

Face Value

2

Mkt Cap (Cr.)

89,280

P/E

48.11

EPS

70.01

Divi. Yield

0.47

Divis Laboratories LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Divis Laboratories LtdNews & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd594.6048.12142,832.41555.550.673,366.01106.10
Divis Laboratories Ltd3,363.1048.1189,416.45461.240.471,656.48313.47
Dr Reddys Laboratories Ltd4,426.5530.9573,580.35443.700.563,397.50979.38
Cipla Ltd787.0523.8563,432.15698.930.513,689.88233.61
Aurobindo Pharma Ltd855.2016.8050,091.89740.510.353,701.14246.88

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Divis Laboratories LtdSummary & Reports

Divis Laboratories Ltd is an India based manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates. The company is engaged in manufacture of leading generic compounds, Nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovator companies. Divis is among the largest pharmaceutical companies in India with a portfolio of 120 products across diverse therapeutic areas. The company has four ... More

Registered Office

1-72-23(P)/DIVIS/303 Divi Towe,Cyber Hills Gachibowli,Hyderabad, Telangana,500032

Tell. : +91-40-23786300/23786352/400
Website : http://www.divislaboratories.com
Email : mail@divislabs.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com

Latest Release by divis-laboratories-ltd-share-price

View

- <

Reco. Price

Feb 18,2021 01:35 PM

Target Price

Target Returns:

0.00%

Result Express

Divis Laboratories Ltd's Q3FY19 standalone net profit rises 68.92% yoy to Rs379.49cr : In-line with Estimates

Mar 01, 2021 03:15 AM

The company’s standalone revenue stood at Rs1,342.92cr, up 29.39% yoy and 4.51% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    06 Feb 2021

    Annc. Date

    23 Jan 2021

    DIVIs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is... More

  • Purpose

    Board Meeting

    Exp. Date

    07 Nov 2020

    Annc. Date

    27 Oct 2020

    DIVIs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is... More